440 related articles for article (PubMed ID: 32998512)
1. Neurological, neuropsychiatric and neurodevelopmental complications of COVID-19.
Pantelis C; Jayaram M; Hannan AJ; Wesselingh R; Nithianantharajah J; Wannan CM; Syeda WT; Choy KC; Zantomio D; Christopoulos A; Velakoulis D; O'Brien TJ
Aust N Z J Psychiatry; 2021 Aug; 55(8):750-762. PubMed ID: 32998512
[TBL] [Abstract][Full Text] [Related]
2. Neurological and Neuropsychiatric Impacts of COVID-19 Pandemic.
Roy D; Ghosh R; Dubey S; Dubey MJ; Benito-León J; Kanti Ray B
Can J Neurol Sci; 2021 Jan; 48(1):9-24. PubMed ID: 32753076
[TBL] [Abstract][Full Text] [Related]
3. Neurological Sequelae of COVID-19.
Ahmad SJ; Feigen CM; Vazquez JP; Kobets AJ; Altschul DJ
J Integr Neurosci; 2022 Apr; 21(3):77. PubMed ID: 35633158
[TBL] [Abstract][Full Text] [Related]
4. Emerging COVID-19 Neurological Manifestations: Present Outlook and Potential Neurological Challenges in COVID-19 Pandemic.
Dewanjee S; Vallamkondu J; Kalra RS; Puvvada N; Kandimalla R; Reddy PH
Mol Neurobiol; 2021 Sep; 58(9):4694-4715. PubMed ID: 34169443
[TBL] [Abstract][Full Text] [Related]
5. The psychiatric and neuropsychiatric repercussions associated with severe infections of COVID-19 and other coronaviruses.
de Sousa Moreira JL; Barbosa SMB; Vieira JG; Chaves NCB; Felix EBG; Feitosa PWG; da Cruz IS; da Silva CGL; Neto MLR
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Mar; 106():110159. PubMed ID: 33147504
[TBL] [Abstract][Full Text] [Related]
6. Evidence of Coronavirus (CoV) Pathogenesis and Emerging Pathogen SARS-CoV-2 in the Nervous System: A Review on Neurological Impairments and Manifestations.
Jha NK; Ojha S; Jha SK; Dureja H; Singh SK; Shukla SD; Chellappan DK; Gupta G; Bhardwaj S; Kumar N; Jeyaraman M; Jain R; Muthu S; Kar R; Kumar D; Goswami VK; Ruokolainen J; Kesari KK; Singh SK; Dua K
J Mol Neurosci; 2021 Nov; 71(11):2192-2209. PubMed ID: 33464535
[TBL] [Abstract][Full Text] [Related]
7. Neurological complications associated with Covid-19; molecular mechanisms and therapeutic approaches.
Mahboubi Mehrabani M; Karvandi MS; Maafi P; Doroudian M
Rev Med Virol; 2022 Nov; 32(6):e2334. PubMed ID: 35138001
[TBL] [Abstract][Full Text] [Related]
8. Neurological complications of coronavirus infection; a comparative review and lessons learned during the COVID-19 pandemic.
Sharifian-Dorche M; Huot P; Osherov M; Wen D; Saveriano A; Giacomini PS; Antel JP; Mowla A
J Neurol Sci; 2020 Oct; 417():117085. PubMed ID: 32871412
[TBL] [Abstract][Full Text] [Related]
9. Neuroinvasion, neurotropic, and neuroinflammatory events of SARS-CoV-2: understanding the neurological manifestations in COVID-19 patients.
Yachou Y; El Idrissi A; Belapasov V; Ait Benali S
Neurol Sci; 2020 Oct; 41(10):2657-2669. PubMed ID: 32725449
[TBL] [Abstract][Full Text] [Related]
10. A Review on SARS-CoV-2-Induced Neuroinflammation, Neurodevelopmental Complications, and Recent Updates on the Vaccine Development.
Karnik M; Beeraka NM; Uthaiah CA; Nataraj SM; Bettadapura ADS; Aliev G; Madhunapantula SV
Mol Neurobiol; 2021 Sep; 58(9):4535-4563. PubMed ID: 34089508
[TBL] [Abstract][Full Text] [Related]
11. [The neurology of COVID-19].
Cuevas-García C; Calderón-Vallejo A; Berrón-Ruiz L
Rev Alerg Mex; 2020; 67(4):338-349. PubMed ID: 33631902
[TBL] [Abstract][Full Text] [Related]
12. Neurological presentations of COVID-19: Findings from the Spanish Society of Neurology neuroCOVID-19 registry.
García-Azorín D; Abildúa MJA; Aguirre MEE; Fernández SF; Moncó JCG; Guijarro-Castro C; Platas MG; Delgado FR; Andrés JML; Ezpeleta D;
J Neurol Sci; 2021 Apr; 423():117283. PubMed ID: 33636661
[TBL] [Abstract][Full Text] [Related]
13. SARS-CoV-2-associated cytokine storm during pregnancy as a possible risk factor for neuropsychiatric disorder development in post-pandemic infants.
Figueiredo CP; Fontes-Dantas FL; da Poian AT; Clarke JR
Neuropharmacology; 2021 Dec; 201():108841. PubMed ID: 34666076
[TBL] [Abstract][Full Text] [Related]
14. Biomedical Perspectives of Acute and Chronic Neurological and Neuropsychiatric Sequelae of COVID-19.
Stefano GB; Büttiker P; Weissenberger S; Ptacek R; Wang F; Esch T; Bilfinger TV; Raboch J; Kream RM
Curr Neuropharmacol; 2022; 20(6):1229-1240. PubMed ID: 34951387
[TBL] [Abstract][Full Text] [Related]
15. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and the Central Nervous System.
De Felice FG; Tovar-Moll F; Moll J; Munoz DP; Ferreira ST
Trends Neurosci; 2020 Jun; 43(6):355-357. PubMed ID: 32359765
[TBL] [Abstract][Full Text] [Related]
16. [Neurological aspects of the COVID-19 pandemic caused by the SARS-CoV-2 coronavirus].
Bereczki D; Stang R; Böjti P; Kovács T
Ideggyogy Sz; 2020 May; 73(05-06):171-175. PubMed ID: 32579306
[TBL] [Abstract][Full Text] [Related]
17. Neurological associations of COVID-19.
Ellul MA; Benjamin L; Singh B; Lant S; Michael BD; Easton A; Kneen R; Defres S; Sejvar J; Solomon T
Lancet Neurol; 2020 Sep; 19(9):767-783. PubMed ID: 32622375
[TBL] [Abstract][Full Text] [Related]
18. Neuroinvasion of severe acute respiratory syndrome corona virus-2 (SARS-CoV-2): future risk of epilepsy.
Kumar H; Gupta R
Int J Neurosci; 2024 Apr; 134(4):323-332. PubMed ID: 35815479
[TBL] [Abstract][Full Text] [Related]
19. SARS-CoV-2 mediated neuroinflammation and the impact of COVID-19 in neurological disorders.
Amruta N; Chastain WH; Paz M; Solch RJ; Murray-Brown IC; Befeler JB; Gressett TE; Longo MT; Engler-Chiurazzi EB; Bix G
Cytokine Growth Factor Rev; 2021 Apr; 58():1-15. PubMed ID: 33674185
[TBL] [Abstract][Full Text] [Related]
20. Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1 284 437 patients.
Taquet M; Sillett R; Zhu L; Mendel J; Camplisson I; Dercon Q; Harrison PJ
Lancet Psychiatry; 2022 Oct; 9(10):815-827. PubMed ID: 35987197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]